Moreover, RvD2 modulated the inflammation by reducing the level of neutrophils in the skeletal muscle of mice undergoing HLI, effectively lowering the level of granulocyte-macrophage colony-stimulating factor (GM-CSF) and the proinflammatory cytokine TNF-α, which are induced in ischemia. Here, CSF2 is linked to ischemia.